SIP sigma pharmaceuticals limited

aspen pharmacare the bidder, page-3

  1. 9,544 Posts.
    lightbulb Created with Sketch. 17
    Thanks for digging that up. No indication of whether consideration will be cash, scrip or mixture of both.

    I suspect initial reaction will be for SIP board to knock back the offer as being too low and opportunistic. Takeover negotiation 101.

    If Aspen walk, then a capital raising will most likely follow at some point. IMO
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.